Regulation of miRNAs Expression by Mutant p53 Gain of Function in Cancer

11Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

The p53 roles have been largely described; among them, cell proliferation and apoptosis control are some of the best studied and understood. Interestingly, the mutations on the six hotspot sites within the region that encodes the DNA-binding domain of p53 give rise to other very different variants. The particular behavior of these variants led to consider p53 mutants as separate oncogene entities; that is, they do not retain wild type functions but acquire new ones, namely Gain-of-function p53 mutants. Furthermore, recent studies have revealed how p53 mutants regulate gene expression and exert oncogenic effects by unbalancing specific microRNAs (miRNAs) levels that provoke epithelial-mesenchymal transition, chemoresistance, and cell survival, among others. In this review, we discuss recent evidence of the crosstalk between miRNAs and mutants of p53, as well as the consequent cellular processes dysregulated.

Cite

CITATION STYLE

APA

Madrigal, T., Hernández-Monge, J., Herrera, L. A., González-De la Rosa, C. H., Domínguez-Gómez, G., Candelaria, M., … Díaz-Chávez, J. (2021, December 6). Regulation of miRNAs Expression by Mutant p53 Gain of Function in Cancer. Frontiers in Cell and Developmental Biology. Frontiers Media S.A. https://doi.org/10.3389/fcell.2021.695723

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free